HEADER BLOOD CLOTTING 09-MAR-00 1E04 TITLE PLASMA BETA ANTITHROMBIN-III COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANTITHROMBIN-III; COMPND 3 CHAIN: I, L SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 OTHER_DETAILS: PLASMA BETA ANTITHROMBIN-III KEYWDS BLOOD CLOTTING, SERPIN EXPDTA X-RAY DIFFRACTION AUTHOR A.J.MCCOY,R.SKINNER,J.-P.ABRAHAMS,X.Y.PEI,R.W.CARRELL REVDAT 8 16-OCT-24 1E04 1 REMARK REVDAT 7 06-DEC-23 1E04 1 HETSYN LINK REVDAT 6 29-JUL-20 1E04 1 COMPND REMARK HETNAM LINK REVDAT 6 2 1 SITE ATOM REVDAT 5 17-AUG-11 1E04 1 REMARK HET HETSYN FORMUL REVDAT 5 2 1 LINK SITE HETATM MASTER REVDAT 5 3 1 VERSN REVDAT 4 24-FEB-09 1E04 1 VERSN REVDAT 3 20-SEP-00 1E04 1 HETATM REVDAT 2 18-AUG-00 1E04 1 HET REVDAT 1 02-JUN-00 1E04 0 JRNL AUTH A.J.MCCOY,X.Y.PEI,R.SKINNER,J.-P.ABRAHAMS,R.W.CARRELL JRNL TITL STRUCTURE OF BETA-ANTITHROMBIN AND THE EFFECT OF JRNL TITL 2 GLYCOSYLATION ON ANTITHROMBIN'S HEPARIN AFFINITY AND JRNL TITL 3 ACTIVITY. JRNL REF J.MOL.BIOL. V. 326 823 2003 JRNL REFN ISSN 0022-2836 JRNL PMID 12581643 JRNL DOI 10.1016/S0022-2836(02)01382-7 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.5 REMARK 3 NUMBER OF REFLECTIONS : 75263 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : SAME AS 2ANT REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1523 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6404 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 240 REMARK 3 SOLVENT ATOMS : 84 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 53.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.972 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.314 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.138 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.765 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.007 ; 0.010 REMARK 3 ANGLE DISTANCE (A) : 0.020 ; 0.015 REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : 0.020 ; 0.020 REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : 0.028 ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : 0.190 ; 0.150 REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : 0.148 ; 0.150 REMARK 3 MULTIPLE TORSION (A) : 0.195 ; 0.150 REMARK 3 H-BOND (X...Y) (A) : 0.112 ; 0.150 REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : 3.800 ; 7.000 REMARK 3 STAGGERED (DEGREES) : 20.000; 15.000 REMARK 3 TRANSVERSE (DEGREES) : 26.200; 20.000 REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.222 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.962 ; 5.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.585 ; 4.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 5.316 ; 6.000 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1E04 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 09-MAR-00. REMARK 100 THE DEPOSITION ID IS D_1290004666. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX7.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.488 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32338 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.5 REMARK 200 DATA REDUNDANCY : 2.500 REMARK 200 R MERGE (I) : 0.08300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 2ANT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.84 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20MG/ML INHIBITORY ANTITHROMBIN-III IN REMARK 280 20MM TRIS HCL PH 7.4 CRYSTALLIZED IN 16% PEG 4000, 50 MM NA/K REMARK 280 PHOSPHATE PH 6.7, PH 6.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 49.66800 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: I, A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CHAIN I ADOPTS THE INHIBITORY CONFORMATION; REMARK 400 CHAIN L ADOPTS THE LATENT CONFORMATION REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS I 1 REMARK 465 GLY I 2 REMARK 465 SER I 3 REMARK 465 PRO I 4 REMARK 465 ILE I 22 REMARK 465 TYR I 23 REMARK 465 ARG I 24 REMARK 465 SER I 25 REMARK 465 PRO I 26 REMARK 465 GLU I 27 REMARK 465 LYS I 28 REMARK 465 LYS I 29 REMARK 465 ALA I 30 REMARK 465 THR I 31 REMARK 465 GLU I 32 REMARK 465 ASP I 33 REMARK 465 GLU I 34 REMARK 465 GLY I 35 REMARK 465 SER I 36 REMARK 465 GLU I 37 REMARK 465 GLN I 38 REMARK 465 LYS I 39 REMARK 465 ILE I 40 REMARK 465 PRO I 41 REMARK 465 GLU I 42 REMARK 465 ALA I 43 REMARK 465 THR I 44 REMARK 465 ASN I 45 REMARK 465 LYS I 432 REMARK 465 HIS L 1 REMARK 465 GLY L 2 REMARK 465 SER L 3 REMARK 465 PRO L 4 REMARK 465 LYS L 28 REMARK 465 LYS L 29 REMARK 465 ALA L 30 REMARK 465 THR L 31 REMARK 465 GLU L 32 REMARK 465 ASP L 33 REMARK 465 GLU L 34 REMARK 465 GLY L 35 REMARK 465 SER L 36 REMARK 465 GLU L 37 REMARK 465 GLN L 38 REMARK 465 LYS L 39 REMARK 465 ILE L 40 REMARK 465 PRO L 41 REMARK 465 VAL L 431 REMARK 465 LYS L 432 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS I 11 CE NZ REMARK 470 ARG I 13 CG CD NE CZ NH1 NH2 REMARK 470 MET I 17 CG SD CE REMARK 470 MET I 20 CG SD CE REMARK 470 ARG I 46 CG CD NE CZ NH1 NH2 REMARK 470 GLN I 100 CG CD OE1 NE2 REMARK 470 LYS I 136 CG CD CE NZ REMARK 470 GLN I 181 CG CD OE1 NE2 REMARK 470 GLU I 209 CD OE1 OE2 REMARK 470 ARG I 235 NE CZ NH1 NH2 REMARK 470 LYS I 257 CD CE NZ REMARK 470 ARG L 24 CB CG CD NE CZ NH1 NH2 REMARK 470 GLU L 42 CG CD OE1 OE2 REMARK 470 ARG L 46 NE CZ NH1 NH2 REMARK 470 LYS L 114 CG CD CE NZ REMARK 470 ARG L 132 CD NE CZ NH1 NH2 REMARK 470 LYS L 188 CE NZ REMARK 470 LYS L 228 CG CD CE NZ REMARK 470 LYS L 257 CD CE NZ REMARK 470 GLU L 289 CB CG CD OE1 OE2 REMARK 470 LYS L 290 CG CD CE NZ REMARK 470 LYS L 297 CG CD CE NZ REMARK 470 GLU L 357 CG CD OE1 OE2 REMARK 470 ASP L 361 CG OD1 OD2 REMARK 470 ASN L 396 CG OD1 ND2 REMARK 470 ARG L 399 CG CD NE CZ NH1 NH2 REMARK 470 PHE L 402 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS L 403 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG I 262 CD - NE - CZ ANGL. DEV. = 10.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA I 10 127.64 -38.17 REMARK 500 PRO I 19 -83.18 -35.82 REMARK 500 ASN I 96 -127.06 50.45 REMARK 500 SER I 112 -79.23 -36.81 REMARK 500 THR I 115 117.67 -15.23 REMARK 500 TYR I 131 69.14 -102.40 REMARK 500 LYS I 133 27.39 -144.37 REMARK 500 LYS I 136 114.25 -21.36 REMARK 500 ASN I 178 37.00 -142.34 REMARK 500 ASN I 208 -153.84 -141.27 REMARK 500 VAL I 263 -159.87 -107.61 REMARK 500 PRO I 407 139.57 -34.76 REMARK 500 ASN I 428 100.08 -161.38 REMARK 500 ARG L 13 -80.16 -11.15 REMARK 500 MET L 17 110.58 -21.89 REMARK 500 MET L 20 -70.18 -41.35 REMARK 500 ASN L 96 -120.57 49.48 REMARK 500 LYS L 133 143.98 169.67 REMARK 500 LYS L 136 102.03 -44.63 REMARK 500 SER L 137 75.24 25.50 REMARK 500 SER L 138 74.28 -176.01 REMARK 500 ASP L 200 56.12 -144.81 REMARK 500 GLU L 205 4.60 81.30 REMARK 500 ASN L 208 -160.72 -125.44 REMARK 500 GLN L 254 148.20 -170.86 REMARK 500 ASP L 360 -6.89 -143.03 REMARK 500 PRO L 397 107.57 -40.40 REMARK 500 VAL L 400 69.73 -100.20 REMARK 500 ALA L 404 -125.50 -129.60 REMARK 500 ARG L 406 75.22 31.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 ALA I 134 -10.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 MAN I 803 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2ANT RELATED DB: PDB REMARK 900 THE 2.6 A STRUCTURE OF ANTITHROMBIN INDICATES A CONFORMATIONAL REMARK 900 CHANGE AT THE HEPARIN BINDING SITE REMARK 900 RELATED ID: 1ANT RELATED DB: PDB REMARK 900 RELATED ID: 1ATH RELATED DB: PDB REMARK 900 RELATED ID: 1BR8 RELATED DB: PDB REMARK 900 RELATED ID: 1DZG RELATED DB: PDB REMARK 900 RELATED ID: 1DZH RELATED DB: PDB REMARK 900 RELATED ID: 1E03 RELATED DB: PDB REMARK 900 RELATED ID: 1E05 RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 ANT3_HUMAN RESIDUE NUMBERING IS FROM START REMARK 999 OF ANTITHROMBIN-III LEADER SEQUENCE. REMARK 999 STRUCTURE RESIDUE NUMBERING IS FROM START OF REMARK 999 MATURE ANTITHROMBIN-III REMARK 999 REMARK 999 RESIDUES NOT MODELLED HAD POOR ELECTRON DENSITY DBREF 1E04 L 1 432 UNP P01008 ANT3_HUMAN 33 464 DBREF 1E04 I 1 432 UNP P01008 ANT3_HUMAN 33 464 SEQRES 1 I 432 HIS GLY SER PRO VAL ASP ILE CYS THR ALA LYS PRO ARG SEQRES 2 I 432 ASP ILE PRO MET ASN PRO MET CYS ILE TYR ARG SER PRO SEQRES 3 I 432 GLU LYS LYS ALA THR GLU ASP GLU GLY SER GLU GLN LYS SEQRES 4 I 432 ILE PRO GLU ALA THR ASN ARG ARG VAL TRP GLU LEU SER SEQRES 5 I 432 LYS ALA ASN SER ARG PHE ALA THR THR PHE TYR GLN HIS SEQRES 6 I 432 LEU ALA ASP SER LYS ASN ASP ASN ASP ASN ILE PHE LEU SEQRES 7 I 432 SER PRO LEU SER ILE SER THR ALA PHE ALA MET THR LYS SEQRES 8 I 432 LEU GLY ALA CYS ASN ASP THR LEU GLN GLN LEU MET GLU SEQRES 9 I 432 VAL PHE LYS PHE ASP THR ILE SER GLU LYS THR SER ASP SEQRES 10 I 432 GLN ILE HIS PHE PHE PHE ALA LYS LEU ASN CYS ARG LEU SEQRES 11 I 432 TYR ARG LYS ALA ASN LYS SER SER LYS LEU VAL SER ALA SEQRES 12 I 432 ASN ARG LEU PHE GLY ASP LYS SER LEU THR PHE ASN GLU SEQRES 13 I 432 THR TYR GLN ASP ILE SER GLU LEU VAL TYR GLY ALA LYS SEQRES 14 I 432 LEU GLN PRO LEU ASP PHE LYS GLU ASN ALA GLU GLN SER SEQRES 15 I 432 ARG ALA ALA ILE ASN LYS TRP VAL SER ASN LYS THR GLU SEQRES 16 I 432 GLY ARG ILE THR ASP VAL ILE PRO SER GLU ALA ILE ASN SEQRES 17 I 432 GLU LEU THR VAL LEU VAL LEU VAL ASN THR ILE TYR PHE SEQRES 18 I 432 LYS GLY LEU TRP LYS SER LYS PHE SER PRO GLU ASN THR SEQRES 19 I 432 ARG LYS GLU LEU PHE TYR LYS ALA ASP GLY GLU SER CYS SEQRES 20 I 432 SER ALA SER MET MET TYR GLN GLU GLY LYS PHE ARG TYR SEQRES 21 I 432 ARG ARG VAL ALA GLU GLY THR GLN VAL LEU GLU LEU PRO SEQRES 22 I 432 PHE LYS GLY ASP ASP ILE THR MET VAL LEU ILE LEU PRO SEQRES 23 I 432 LYS PRO GLU LYS SER LEU ALA LYS VAL GLU LYS GLU LEU SEQRES 24 I 432 THR PRO GLU VAL LEU GLN GLU TRP LEU ASP GLU LEU GLU SEQRES 25 I 432 GLU MET MET LEU VAL VAL HIS MET PRO ARG PHE ARG ILE SEQRES 26 I 432 GLU ASP GLY PHE SER LEU LYS GLU GLN LEU GLN ASP MET SEQRES 27 I 432 GLY LEU VAL ASP LEU PHE SER PRO GLU LYS SER LYS LEU SEQRES 28 I 432 PRO GLY ILE VAL ALA GLU GLY ARG ASP ASP LEU TYR VAL SEQRES 29 I 432 SER ASP ALA PHE HIS LYS ALA PHE LEU GLU VAL ASN GLU SEQRES 30 I 432 GLU GLY SER GLU ALA ALA ALA SER THR ALA VAL VAL ILE SEQRES 31 I 432 ALA GLY ARG SER LEU ASN PRO ASN ARG VAL THR PHE LYS SEQRES 32 I 432 ALA ASN ARG PRO PHE LEU VAL PHE ILE ARG GLU VAL PRO SEQRES 33 I 432 LEU ASN THR ILE ILE PHE MET GLY ARG VAL ALA ASN PRO SEQRES 34 I 432 CYS VAL LYS SEQRES 1 L 432 HIS GLY SER PRO VAL ASP ILE CYS THR ALA LYS PRO ARG SEQRES 2 L 432 ASP ILE PRO MET ASN PRO MET CYS ILE TYR ARG SER PRO SEQRES 3 L 432 GLU LYS LYS ALA THR GLU ASP GLU GLY SER GLU GLN LYS SEQRES 4 L 432 ILE PRO GLU ALA THR ASN ARG ARG VAL TRP GLU LEU SER SEQRES 5 L 432 LYS ALA ASN SER ARG PHE ALA THR THR PHE TYR GLN HIS SEQRES 6 L 432 LEU ALA ASP SER LYS ASN ASP ASN ASP ASN ILE PHE LEU SEQRES 7 L 432 SER PRO LEU SER ILE SER THR ALA PHE ALA MET THR LYS SEQRES 8 L 432 LEU GLY ALA CYS ASN ASP THR LEU GLN GLN LEU MET GLU SEQRES 9 L 432 VAL PHE LYS PHE ASP THR ILE SER GLU LYS THR SER ASP SEQRES 10 L 432 GLN ILE HIS PHE PHE PHE ALA LYS LEU ASN CYS ARG LEU SEQRES 11 L 432 TYR ARG LYS ALA ASN LYS SER SER LYS LEU VAL SER ALA SEQRES 12 L 432 ASN ARG LEU PHE GLY ASP LYS SER LEU THR PHE ASN GLU SEQRES 13 L 432 THR TYR GLN ASP ILE SER GLU LEU VAL TYR GLY ALA LYS SEQRES 14 L 432 LEU GLN PRO LEU ASP PHE LYS GLU ASN ALA GLU GLN SER SEQRES 15 L 432 ARG ALA ALA ILE ASN LYS TRP VAL SER ASN LYS THR GLU SEQRES 16 L 432 GLY ARG ILE THR ASP VAL ILE PRO SER GLU ALA ILE ASN SEQRES 17 L 432 GLU LEU THR VAL LEU VAL LEU VAL ASN THR ILE TYR PHE SEQRES 18 L 432 LYS GLY LEU TRP LYS SER LYS PHE SER PRO GLU ASN THR SEQRES 19 L 432 ARG LYS GLU LEU PHE TYR LYS ALA ASP GLY GLU SER CYS SEQRES 20 L 432 SER ALA SER MET MET TYR GLN GLU GLY LYS PHE ARG TYR SEQRES 21 L 432 ARG ARG VAL ALA GLU GLY THR GLN VAL LEU GLU LEU PRO SEQRES 22 L 432 PHE LYS GLY ASP ASP ILE THR MET VAL LEU ILE LEU PRO SEQRES 23 L 432 LYS PRO GLU LYS SER LEU ALA LYS VAL GLU LYS GLU LEU SEQRES 24 L 432 THR PRO GLU VAL LEU GLN GLU TRP LEU ASP GLU LEU GLU SEQRES 25 L 432 GLU MET MET LEU VAL VAL HIS MET PRO ARG PHE ARG ILE SEQRES 26 L 432 GLU ASP GLY PHE SER LEU LYS GLU GLN LEU GLN ASP MET SEQRES 27 L 432 GLY LEU VAL ASP LEU PHE SER PRO GLU LYS SER LYS LEU SEQRES 28 L 432 PRO GLY ILE VAL ALA GLU GLY ARG ASP ASP LEU TYR VAL SEQRES 29 L 432 SER ASP ALA PHE HIS LYS ALA PHE LEU GLU VAL ASN GLU SEQRES 30 L 432 GLU GLY SER GLU ALA ALA ALA SER THR ALA VAL VAL ILE SEQRES 31 L 432 ALA GLY ARG SER LEU ASN PRO ASN ARG VAL THR PHE LYS SEQRES 32 L 432 ALA ASN ARG PRO PHE LEU VAL PHE ILE ARG GLU VAL PRO SEQRES 33 L 432 LEU ASN THR ILE ILE PHE MET GLY ARG VAL ALA ASN PRO SEQRES 34 L 432 CYS VAL LYS MODRES 1E04 ASN I 96 ASN GLYCOSYLATION SITE MODRES 1E04 ASN I 155 ASN GLYCOSYLATION SITE MODRES 1E04 ASN I 192 ASN GLYCOSYLATION SITE MODRES 1E04 ASN L 96 ASN GLYCOSYLATION SITE MODRES 1E04 ASN L 155 ASN GLYCOSYLATION SITE MODRES 1E04 ASN L 192 ASN GLYCOSYLATION SITE HET NAG A 1 14 HET NAG A 2 14 HET NAG B 1 14 HET NAG B 2 14 HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET NAG D 1 14 HET NAG D 2 14 HET NAG E 1 14 HET NAG E 2 14 HET NAG F 1 14 HET NAG F 2 14 HET BMA F 3 11 HET MAN F 4 11 HET MAN F 5 11 HET MAN I 803 11 HET GOL I 809 6 HET GOL L 810 6 HET PO4 L 811 5 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM GOL GLYCEROL HETNAM PO4 PHOSPHATE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 NAG 12(C8 H15 N O6) FORMUL 5 BMA 2(C6 H12 O6) FORMUL 8 MAN 3(C6 H12 O6) FORMUL 10 GOL 2(C3 H8 O3) FORMUL 12 PO4 O4 P 3- FORMUL 13 HOH *84(H2 O) HELIX 1 AA1 LYS I 11 ILE I 15 5 5 HELIX 2 AA2 TRP I 49 SER I 69 1 21 HELIX 3 AA3 SER I 79 LEU I 92 1 14 HELIX 4 AA4 CYS I 95 PHE I 106 1 12 HELIX 5 AA5 LYS I 107 ILE I 111 5 5 HELIX 6 AA6 ASP I 117 TYR I 131 1 15 HELIX 7 AA7 ASN I 155 GLY I 167 1 13 HELIX 8 AA8 ASP I 174 THR I 194 1 21 HELIX 9 AA9 SER I 230 THR I 234 5 5 HELIX 10 AB1 ALA I 264 GLY I 266 5 3 HELIX 11 AB2 SER I 291 LEU I 299 1 9 HELIX 12 AB3 THR I 300 LEU I 311 1 12 HELIX 13 AB4 LEU I 331 MET I 338 1 8 HELIX 14 AB5 VAL I 341 SER I 345 5 5 HELIX 15 AB6 ALA L 43 SER L 69 1 27 HELIX 16 AB7 SER L 79 LEU L 92 1 14 HELIX 17 AB8 CYS L 95 PHE L 106 1 12 HELIX 18 AB9 THR L 115 ARG L 132 1 18 HELIX 19 AC1 ASN L 155 GLY L 167 1 13 HELIX 20 AC2 ASP L 174 THR L 194 1 21 HELIX 21 AC3 SER L 230 THR L 234 5 5 HELIX 22 AC4 SER L 291 GLU L 298 1 8 HELIX 23 AC5 THR L 300 GLU L 310 1 11 HELIX 24 AC6 LEU L 331 MET L 338 1 8 HELIX 25 AC7 VAL L 341 SER L 345 5 5 SHEET 1 AA1 7 ILE I 76 LEU I 78 0 SHEET 2 AA1 7 THR I 419 VAL I 426 -1 O ARG I 425 N ILE I 76 SHEET 3 AA1 7 PHE I 408 GLU I 414 -1 N GLU I 414 O THR I 419 SHEET 4 AA1 7 ILE I 279 LEU I 285 -1 N VAL I 282 O PHE I 411 SHEET 5 AA1 7 THR I 267 PRO I 273 -1 N LEU I 272 O MET I 281 SHEET 6 AA1 7 SER I 246 VAL I 263 -1 N VAL I 263 O THR I 267 SHEET 7 AA1 7 ARG I 235 TYR I 240 -1 N GLU I 237 O ALA I 249 SHEET 1 AA2 8 ILE I 76 LEU I 78 0 SHEET 2 AA2 8 THR I 419 VAL I 426 -1 O ARG I 425 N ILE I 76 SHEET 3 AA2 8 PHE I 408 GLU I 414 -1 N GLU I 414 O THR I 419 SHEET 4 AA2 8 ILE I 279 LEU I 285 -1 N VAL I 282 O PHE I 411 SHEET 5 AA2 8 THR I 267 PRO I 273 -1 N LEU I 272 O MET I 281 SHEET 6 AA2 8 SER I 246 VAL I 263 -1 N VAL I 263 O THR I 267 SHEET 7 AA2 8 GLU I 312 PRO I 321 -1 O VAL I 318 N GLN I 254 SHEET 8 AA2 8 THR I 401 LYS I 403 1 O PHE I 402 N HIS I 319 SHEET 1 AA3 5 LEU I 170 LEU I 173 0 SHEET 2 AA3 5 LYS I 139 ASP I 149 1 N GLY I 148 O LEU I 173 SHEET 3 AA3 5 LEU I 213 LEU I 224 -1 O VAL I 214 N PHE I 147 SHEET 4 AA3 5 VAL I 364 VAL I 375 1 O PHE I 368 N LEU I 215 SHEET 5 AA3 5 PHE I 323 SER I 330 -1 N PHE I 329 O HIS I 369 SHEET 1 AA4 4 LEU I 170 LEU I 173 0 SHEET 2 AA4 4 LYS I 139 ASP I 149 1 N GLY I 148 O LEU I 173 SHEET 3 AA4 4 LEU I 213 LEU I 224 -1 O VAL I 214 N PHE I 147 SHEET 4 AA4 4 GLY I 379 SER I 380 -1 O SER I 380 N GLY I 223 SHEET 1 AA5 2 LEU I 152 PHE I 154 0 SHEET 2 AA5 2 ILE I 354 ALA I 356 -1 O VAL I 355 N THR I 153 SHEET 1 AA6 8 ALA I 387 ILE I 390 0 SHEET 2 AA6 8 GLU L 312 SER L 330 1 O HIS L 319 N VAL I 389 SHEET 3 AA6 8 SER L 246 ARG L 262 -1 N GLN L 254 O VAL L 318 SHEET 4 AA6 8 VAL L 364 VAL L 375 0 SHEET 5 AA6 8 GLY L 379 ILE L 390 -1 O ALA L 383 N PHE L 372 SHEET 6 AA6 8 LEU L 213 LEU L 224 -1 N PHE L 221 O ALA L 382 SHEET 7 AA6 8 SER L 138 ASP L 149 -1 N ARG L 145 O VAL L 216 SHEET 8 AA6 8 ALA L 168 LEU L 173 1 O GLN L 171 N LEU L 146 SHEET 1 AA7 8 ILE L 76 LEU L 78 0 SHEET 2 AA7 8 THR L 419 VAL L 426 -1 O MET L 423 N LEU L 78 SHEET 3 AA7 8 PHE L 408 GLU L 414 -1 N VAL L 410 O GLY L 424 SHEET 4 AA7 8 ILE L 279 LEU L 285 -1 N ILE L 284 O LEU L 409 SHEET 5 AA7 8 GLN L 268 PRO L 273 -1 N LEU L 272 O MET L 281 SHEET 6 AA7 8 SER L 246 ARG L 262 -1 N ARG L 259 O GLU L 271 SHEET 7 AA7 8 GLU L 312 SER L 330 -1 O VAL L 318 N GLN L 254 SHEET 8 AA7 8 ARG L 235 TYR L 240 0 SHEET 1 AA8 2 THR L 153 PHE L 154 0 SHEET 2 AA8 2 VAL L 355 GLU L 357 -1 O ALA L 356 N THR L 153 SSBOND 1 CYS I 8 CYS I 128 1555 1555 2.03 SSBOND 2 CYS I 21 CYS I 95 1555 1555 2.03 SSBOND 3 CYS I 247 CYS I 430 1555 1555 2.03 SSBOND 4 CYS L 8 CYS L 128 1555 1555 2.02 SSBOND 5 CYS L 21 CYS L 95 1555 1555 2.02 SSBOND 6 CYS L 247 CYS L 430 1555 1555 2.02 LINK ND2 ASN I 96 C1 NAG A 1 1555 1555 1.39 LINK ND2 ASN I 155 C1 NAG B 1 1555 1555 1.39 LINK ND2 ASN I 192 C1 NAG C 1 1555 1555 1.38 LINK ND2 ASN L 96 C1 NAG D 1 1555 1555 1.38 LINK ND2 ASN L 155 C1 NAG E 1 1555 1555 1.39 LINK ND2 ASN L 192 C1 NAG F 1 1555 1555 1.37 LINK O4 NAG A 1 C1 NAG A 2 1555 1555 1.41 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.42 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.40 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.41 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.40 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.41 LINK O4 NAG F 1 C1 NAG F 2 1555 1555 1.41 LINK O4 NAG F 2 C1 BMA F 3 1555 1555 1.38 LINK O3 BMA F 3 C1 MAN F 4 1555 1555 1.38 LINK O6 BMA F 3 C1 MAN F 5 1555 1555 1.42 CRYST1 62.050 99.336 88.593 90.00 102.29 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016116 0.000000 0.003511 0.00000 SCALE2 0.000000 0.010067 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011552 0.00000